Saturday 17 October 2026
Export CNTN’s income statement to Excel — free account
Canton Strategic Holdings, Inc.
CNTN Healthcare Biotechnology
In the quarter to June 2026, EPS grew 85.9% and free cash flow fell 600.4%, each against the same quarter a year earlier.
1.70
0.17
−9.09%
Follow CNTN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (43.10%) | (34.42%) | (17.99%) | (225.01%) |
+8 more TTM periods Free account |
|
| (34.60%) | (27.53%) | (13.74%) | (159.36%) | ||
ROIC |
(8.11%) | (7.94%) | (3.26%) | 0.00% | |
Return on Tangible Assets |
(254.25%) | (192.44%) | (254.73%) | (167.66%) | |
Free Cash Flow per Share |
(0.10) | (0.10) | (0.50) | (1.40) | |
Free Cash Flow |
(22.17) | (21.07) | (16.13) | (8.72) | |
| Other line items | |||||
Cash ROIC |
(4.50%) | (4.12%) | (3.93%) | (63.19%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
— | — | (707.96) | (395.08) | |
Operating CF/Net income |
0.23 | 0.26 | 0.45 | 0.85 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.10) | (0.10) | (0.50) | (1.40) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates